Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119509) titled 'Study on the Application of Quantitative Detection of Feto-Maternal Hemorrhage in the Diagnosis of Hemolytic Disease of the Newborn' on Feb. 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Hemolytic Disease of the Newborn
Intervention:
Fetomaternal hemorrhage (FMH) values >= 0.5%
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Fetomaternal hemorrhage (FMH) values >= 0.5%;Fetomaternal hemorrhage (FMH) value < 0.5%:100;
Countries of Recruitment:
China
To know more, visit http...